German MS and Pregnancy Registryocrelizumabnatalizumabofatumumabmultiple sclerosisrituximabneuromyelitis optica spectrum disordermAb-BFdisease-modifying therapyDMT
… monocentric cohort study of infants, born in 2013–2022, in the German MS and Pregnancy Registry, followed up 6–36 months post partum via telephone interviews. …